Skip navigation
About us
Company Overview
Leadership Team
Corporate Governance
Partnering
History
Career
Technology
LAG-3 Technology
Key Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors & Media
What's new
Stock Information
Events
ASX & SEC Filings
FAQ
Presentations
Video
Contacts
Contact
Patient Contact
Electronic Communications
E-MAIL UPDATES
Click here to join
our Electronic Communications.
ASX:
-
NASDAQ:
-
Skip navigation
About us
Company Overview
Leadership Team
Corporate Governance
Partnering
History
Career
Technology
LAG-3 Technology
Key Publications
Pipeline
Clinical Pipeline
Clinical Trials
Investors & Media
What's new
Stock Information
Events
ASX & SEC Filings
FAQ
Presentations
Video
Contacts
Contact
Patient Contact
Electronic Communications
Who we are?
Management
.
Marc Voigt
Executive Director & Chief Executive Officer (CEO)
Frédéric Triebel, MD Ph.D.
Chief Scientific Officer & Chief Medical Officer
Deanne Miller
Chief Operating Officer, General Counsel & Company Secretary
Christian Mueller
Director Clinical Development and Regulatory Affairs
Michael Buchholz, Ph.D.
Director of Manufacturing
Claudia Jacoby, Ph.D.
Director of Manufacturing
James Flinn, Ph.D.
Intellectual Property and Innovation Director
David Fang
Finance Director & Assistant Company Secretary
Board
.
Russell Howard, Ph.D.
Non-Executive Chairman
Grant Chamberlain
Non-Executive Director
Marc Voigt
Executive Director & Chief Executive Officer (CEO)
Pete Meyers
Non-Executive Director and Deputy Chairman
Advisory board
.
Dr. Luc Dirix
Prof. Salah-Eddin Al-Batran
Dr. Samson Fung
Prof. Martine J. Piccart
Prof. David Cameron